The Evaluation and Optimal Use of Rituximab in Lymphoid Malignancies

Blood and Lymphatic Cancer: Targets and Therapy
doi 10.2147/blctt.s15561
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

CDK6 and P16INK4a in Lymphoid Malignancies

Oncotarget
Oncology
2013English

Novel Immunotherapies in Lymphoid Malignancies

Nature Reviews Clinical Oncology
Oncology
2015English

Immune Checkpoint Blockade in Lymphoid Malignancies

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2016English

Del(6q) Abnormalities in Lymphoid Malignancies

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Nationwide Statistical Analysis of Lymphoid Malignancies in Korea

Cancer Research and Treatment
Cancer ResearchOncology
2018English

T(6;12)(p21;p13) in Lymphoid Malignancies

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Telomere Protein Complexes and Their Role in Lymphoid Malignancies

Frontiers in Bioscience - Scholar
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

Retraction: DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies

Clinical Cancer Research
Cancer ResearchOncology
2012English

EZH2 Abnormalities in Lymphoid Malignancies: Underlying Mechanisms and Therapeutic Implications

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy